Cargando…
Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the ac...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621880/ https://www.ncbi.nlm.nih.gov/pubmed/34830024 http://dx.doi.org/10.3390/ijms222212142 |